Passer au contenu
OTR3, Science for Regeneration
  • Qui sommes-nous ?
  • Notre technologie
    • Technologie des RGTA®
    • Pipeline
    • Publications
  • Nos engagements
  • Notre activité commerciale
    • Dispositif médical pour l’homme
      • Cacipliq 20®
    • Produits vétérinaires
      • Clerapliq®
      • Dermapliq® Spray
    • Cosmétique Sportive
  • Actualités
  • Contact
  • Français
    • Français
    • English

florent.pascal@otr3.com

  • April 2025 – Poster Session on the optimization of extracellular vesicles-based therapy in the treatment of ischemic stroke during the ISEV at Vienna

    Neuroprotection | News

    OPTIMIZATION OF EXTRACELLULAR VESICLES-BASED THERAPY IN THE TREATMENT OF ISCHEMIC STROKE Poster Session on the Friday 25th of April at 4:30PM at ISEV Congress in Vienna Ons BEN HADJ HASSEN1, Sarah RAZAFINDRAKOTO2, Jérôme TOUTAIN1, Isis BLANCHARD1, Viktoriia IVANOVA1, Charlène RENOULT1,3, Xavier LAFFRAY4, Minh-Bao HUYNH4, Carole BRUNAUD1, Karim BORDJI1, Gael LE [...]

  • March 2025 – OTR3 Announces First Patient Enrollment in Phase 2 Stroke Clinical Trial

    Neuroprotection | News

    OTR3 has initiated its Phase 2 clinical trial for OTR4132, a novel neuroprotector designed to enhance functional recovery in acute ischemic stroke patients following thrombectomy. A first-in-human pilot study, MATRISS, was conducted across three centers in France, evaluating six escalating doses. The results were promising, demonstrating favorable safety and efficacy [...]

  • Overview of 10 years of practice with CACIPLIQ20® matrix therapy as a healing agent for hard to heal wounds: Efficacy, cost-effectiveness and future perspectives

    Cacipliq 20 | Media Publications | RGTA technology

    Overview of 10 years of practice with CACIPLIQ20® matrix therapy as a healing agent for hard to heal wounds: Efficacy, cost-effectiveness and future perspectives Background: Chronic, non-healing wounds remain a major challenge for health care practitioners and for society in general, both in terms of the enormous economic burden [...]

  • February 2025 – Next-Generation Biomaterials for Wound Healing

    Dermatology | Media Publications

    Merel Gansevoort 1 , SabineWentholt 1, Gaia Li Vecchi 1, Marjolein de Vries 1, Elly M. M. Versteeg 1, Bouke K. H. L. Boekema 2,3 , Agnes Choppin 4, Denis Barritault 4, Franck Chiappini 4 , Toin H. van Kuppevelt 1 and Willeke F. Daamen 1,* Fibrosis after full-thickness wound [...]

  • November 2024 – Successful Development of Human Precision-Cut Lung Slice (hPCLS) Model for Studying Lung Disease

    Lungs/Poumons | Media Publications

    Laurie Perdigon (1) , Manon Barthe (1) , Hanan Osman-Ponchet (1) , Agnes Choppin (2) , Franck Chiappini (2) Human precision-cut lung slices (hPCLS) are a promising ex vivo model for respiratory research. These thin, precisely-cut tissues, obtained from fresh lungs using a vibrating microtome, retain the native 3D architecture [...]

  • November 2024 – Screening Anti-Fibrotic Drugs Using Primary Human Pulmonary Fibroblasts: A Cell Migration and Gene Expression Assay

    Lungs/Poumons | Media Publications

    Manon Barthe (1) , Laurie Perdigon (1) , Hanan Osman-Ponchet (1) , Agnès Choppin (2) , Franck Chiapini (2) Pulmonary fibrosis is a progressive, restrictive lung disease characterized by scarring and stiffening of lung tissue, ultimately leading to respiratory failure. This condition is driven by the excessive proliferation and migration [...]

  • November 2024 – SUCCESSFUL GENERATION OF THREE-DIMENSIONAL HUMAN PRECISION-CUT LUNG SLICES FOR PULMONARY FIBROSIS MODELING

    Lungs/Poumons | Media Publications

    Laurie Perdigon (1) , Manon Barthe (1) , Jean-Paul Thénot (1) , Franck Chiappini (2) , Agnes Choppin (2) , Hanan Osman-Ponchet (1) Occurrence of diffuse alveolar damage is a real storm in the course of pulmonary diseases leading to an acute and/or chronic inflammatory processes with poorly understood etiologies [...]

  • November 2024 – Advances in In Vitro Modeling of Pulmonary Fibrosis: Focus on Precision-Cut Lung Slices (PCLS) Model

    Latest Publications | Lungs/Poumons | Media Publications | On-going research

    Hanan Osman-Ponchet (1) , Laurie Perdigon (1) , Manon Barthe (1) , Ines Metatla (2) , Kevin Rogers (2) , Ida Chiara Guerrera (2) , Franck Chiappini (3) , Agnes Choppin (3) Pulmonary fibrosis is a progressive lung disease characterized by scarring and stiffening of lung tissue, ultimately leading to [...]

  • Juin 2024 – SUCCESSFUL GENERATION OF THREE-DIMENSIONAL HUMAN PRECISION-CUT LUNG SLICES FOR PULMONARY FIBROSIS MODELING

    News | Non classé

    Nous sommes ravis de présenter, à l'occasion du congrès ESTIV 2024 à Prague, un poster et une présentation orale sur notre projet MAT-PL (ANR-MAT-PL/ANR-22-CE18-0013), en collaboration avec PKDERM, sur "SUCCESSFUL GENERATION OF THREE-DIMENSIONAL HUMAN PRECISION-CUT LUNG SLICES FOR PULMONARY FIBROSIS MODELING". ESTIV_00118[74]

12Suivant
OTR3, Science for Regeneration

Organes Tissus Régénération Réparation Remplacement

©2025 | OTR3 | All rights reserved.

  • Politique de confidentialité
  • Mentions légales
Kiwik, agence web à Orléans
Page load link
Aller en haut